Comparison of insulin lispro low mixture with insulin glargine when initiating and intensifying insulin therapy as required in patients with type 2 diabetes who have inadequate glycemic control on oral antihyperglycemic medication.

Trial Profile

Comparison of insulin lispro low mixture with insulin glargine when initiating and intensifying insulin therapy as required in patients with type 2 diabetes who have inadequate glycemic control on oral antihyperglycemic medication.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jun 2017

At a glance

  • Drugs Insulin neutral protamine lispro/insulin lispro (Primary) ; Insulin glargine; Insulin lispro
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms PARADIGM
  • Sponsors Eli Lilly
  • Most Recent Events

    • 13 Jun 2017 Results of post hoc analysis evaluating glycemic profiles of lispro Mix25-treated patients, presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
    • 05 Jun 2012 Primary endpoint 'Proportion-of-glycosylated-haemoglobin' has been met according to results published in Diabetic Medicine.
    • 05 Jun 2012 Results published in Diabetic Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top